{"denomUnitsSelected":"Participants","description":"Categorical data analysis and logistic regression will be used to correlated biomarkers with and clinical outcome (e.g., response, clinical benefit, time to progression, progression free survival, and survival) within each study component. Kaplan-Meier methodology and Cox proportional hazards models will be used to evaluate time to event endpoints.","reportingStatus":"NOT_POSTED","timeFrame":"Up to week 6","title":"Selected Biomarkers Measured in Tumor Tissue","type":"OTHER_PRE_SPECIFIED"}